Success Metrics

Clinical Success Rate
83.3%

Based on 10 completed trials

Completion Rate
83%(10/12)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(17%)

Phase Distribution

Ph not_applicable
12
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
N/ANon-phased studies
12(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Terminated(2)

Detailed Status

Completed10
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
83.3%
Most Advanced
N/A

Trials by Phase

N/A12 (100.0%)

Trials by Status

completed1083%
terminated217%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12